Clinical Perspective Roundtable Discussion
Subscribed: 1Played: 5
Subscribe
Description
Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD
discuss important head-to-head data between a GLP-1 RA
and DPP-4 inhibitor as an important consideration when
making clinical decisions for patients with T2D.
Episode 2: Listen to the second part of this 3-part series where
two clinicians have an in-depth discussion about a head-to-head study comparing two oral antidiabetic therapies.
Episode 3: Hear this clinical panel share a quick overview of
the patient support resources available to help patients with
T2D get off to a successful start with this GLP-1 RA
treatment option.
This podcast is sponsored by Novo Nordisk Inc. and is
intended for clinicians.
discuss important head-to-head data between a GLP-1 RA
and DPP-4 inhibitor as an important consideration when
making clinical decisions for patients with T2D.
Episode 2: Listen to the second part of this 3-part series where
two clinicians have an in-depth discussion about a head-to-head study comparing two oral antidiabetic therapies.
Episode 3: Hear this clinical panel share a quick overview of
the patient support resources available to help patients with
T2D get off to a successful start with this GLP-1 RA
treatment option.
This podcast is sponsored by Novo Nordisk Inc. and is
intended for clinicians.
3 Episodes
Reverse
Comments




